Literature DB >> 15735161

Aberrations in the mismatch repair genes and the clinical impact on oesophageal squamous carcinomas from a high incidence area in South Africa.

R Naidoo1, A Ramburan, A Reddi, R Chetty.   

Abstract

AIMS: To investigate the incidence of genetic aberrations in the DNA repair genes in a cohort of oesophageal cancers.
METHODS: One hundred oesophagectomy samples of squamous cell carcinoma were studied. Normal and tumour DNA were isolated using a standard phenol/chloroform extraction procedure. Six recommended microsatellite loci with high informativity were analysed. The following markers were used: D2S123 (2p), D3S659 (3p), D3S1255 (3p), Bat 25 (4q), Bat 26 (2p), and Bat 40 (1p). The results were analysed using software attached to an automated DNA sequencer. The molecular data were then correlated with clinicopathological parameters.
RESULTS: The incidence of microsatellite instability and loss of heterozygosity was very low. There was no significant correlation between the clinicopathological and molecular data. However, D2S123 genetic abnormalities were seen more frequently in both moderately and well differentiated tumours than in poorly differentiated tumours (p = 0.033). Follow up data were available for only 67 of the 100 patients. Fifty patients were alive and 17 patients had died.
CONCLUSION: Low frequencies of genetic aberrations in these mismatch repair loci are found in squamous carcinomas of the oesophagus from a high incidence area in South Africa.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15735161      PMCID: PMC1770598          DOI: 10.1136/jcp.2003.014290

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  26 in total

1.  A comparative microsatellite analysis of colorectal cancer in patients <35 years and >50 years of age.

Authors:  R Naidoo; M Tarin; R Chetty
Journal:  Am J Gastroenterol       Date:  2000-11       Impact factor: 10.864

2.  Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in China.

Authors:  N Hu; J Huang; M R Emmert-Buck; Z Z Tang; M J Roth; C Wang; S M Dawsey; G Li; W J Li; Q H Wang; X Y Han; T Ding; C Giffen; A M Goldstein; P R Taylor
Journal:  Clin Cancer Res       Date:  2001-04       Impact factor: 12.531

3.  Esophageal squamous cell carcinomas with DNA replication errors (RER+) are associated with p16/pRb loss and wild-type p53.

Authors:  R Mathew; S Arora; M Mathur; T K Chattopadhyay; R Ralhan
Journal:  J Cancer Res Clin Oncol       Date:  2001-10       Impact factor: 4.553

4.  p53 and cyclin A protein expression in squamous carcinoma of the oesophagus.

Authors:  R Chetty; S Simelane
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

Review 5.  DNA mismatch repair and cancer.

Authors:  P Peltomäki
Journal:  Mutat Res       Date:  2001-03       Impact factor: 2.433

6.  Allelic imbalance and microsatellite instability in chromosomes 2p, 3p, 5q, and 18q in esophageal squamous carcinoma in patients from South Africa.

Authors:  R Naidoo; M Tarin; A Reddi; R Chetty
Journal:  Diagn Mol Pathol       Date:  1999-09

Review 7.  Mismatch repair and the hereditary non-polyposis colorectal cancer syndrome (HNPCC).

Authors:  Annegret Müller; Richard Fishel
Journal:  Cancer Invest       Date:  2002       Impact factor: 2.176

8.  Polymorphisms and mutations found in the regions flanking exons 5 to 8 of the TP53 gene in a population at high risk for esophageal cancer in South Africa.

Authors:  Marelette Vos; Craig H Adams; Thomas C Victor; Paul D van Helden
Journal:  Cancer Genet Cytogenet       Date:  2003-01-01

9.  Microsatellite instability is often observed in esophageal carcinoma patients with allelic loss in the FHIT/FRA3B locus.

Authors:  Koshi Mimori; Hiroshi Inoue; Takeshi Shiraishi; Ayumi Matsuyama; Ken-ichi Mafune; Yoichi Tanaka; Masaki Mori
Journal:  Oncology       Date:  2003       Impact factor: 2.935

Review 10.  Role of DNA mismatch repair defects in the pathogenesis of human cancer.

Authors:  Päivi Peltomäki
Journal:  J Clin Oncol       Date:  2003-03-15       Impact factor: 44.544

View more
  8 in total

1.  Aberrant methylation of different DNA repair genes demonstrates distinct prognostic value for esophageal cancer.

Authors:  Zhi-Qiang Ling; Pei Li; Ming-Hua Ge; Fu-Jun Hu; Xian-Hua Fang; Zi-Min Dong; Wei-Min Mao
Journal:  Dig Dis Sci       Date:  2011-06-15       Impact factor: 3.199

2.  Abnormalities of chromosome 17 in oesophageal cancer.

Authors:  Revendran Moodley; Anunathan Reddi; Runjan Chetty; Richard Naidoo
Journal:  J Clin Pathol       Date:  2006-10-17       Impact factor: 3.411

Review 3.  The promise of PD-1 inhibitors in gastro-esophageal cancers: microsatellite instability vs. PD-L1.

Authors:  Zhaohui Jin; Harry H Yoon
Journal:  J Gastrointest Oncol       Date:  2016-10

4.  XAF1 is frequently methylated in human esophageal cancer.

Authors:  Xiang-Yu Chen; Qiao-Yu He; Ming-Zhou Guo
Journal:  World J Gastroenterol       Date:  2012-06-14       Impact factor: 5.742

5.  The cumulative effects of polymorphisms in the DNA mismatch repair genes and tobacco smoking in oesophageal cancer risk.

Authors:  Matjaz Vogelsang; Yabing Wang; Nika Veber; Lamech M Mwapagha; M Iqbal Parker
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

6.  Accumulated promoter methylation as a potential biomarker for esophageal cancer.

Authors:  Xianzhen Peng; Hengchuan Xue; Lingshuang Lü; Peiyi Shi; Jianping Wang; Jianming Wang
Journal:  Oncotarget       Date:  2017-01-03

7.  Systematic Review of Genetic Factors in the Etiology of Esophageal Squamous Cell Carcinoma in African Populations.

Authors:  Hannah Simba; Helena Kuivaniemi; Vittoria Lutje; Gerard Tromp; Vikash Sewram
Journal:  Front Genet       Date:  2019-08-02       Impact factor: 4.599

8.  Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study.

Authors:  L C Hewitt; I Z Inam; Y Saito; T Yoshikawa; A Quaas; A Hoelscher; E Bollschweiler; G E Fazzi; V Melotte; R E Langley; M Nankivell; D Cunningham; W Allum; G G Hutchins; H I Grabsch
Journal:  Eur J Cancer       Date:  2018-03-20       Impact factor: 9.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.